Aristotelis Chatziioannou

19PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 22, 2026
IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

|Jul 29, 2025
Multiomics Integration of Parkinson's Disease Datasets Reveals Unexpected Roles of IRE1 in Its Pathology.

Bianka Alexandra Pasat, Matthieu Moncan, Eleftherios Pilalis

|Oct 04, 2023
Design and Synthesis of Novel 2-Acetamido, 6-Carboxamide Substituted Benzothiazoles as Potential BRAFV600E Inhibitors - In vitro Evaluation of their Antiproliferative Activity.

Yakinthi Batsi, Georgia Antonopoulou, Theano Fotopoulou

|Feb 25, 2023
ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid.

Aggeliki K Meligova, Dimitra Siakouli, Sotiria Stasinopoulou

|Feb 11, 2023
A Comprehensive Analysis of Cutaneous Melanoma Patients in Greece Based on Multi-Omic Data.

Georgia Kontogianni, Konstantinos Voutetakis, Georgia Piroti

|Feb 08, 2023
Dual IRE1 RNase functions dictate glioblastoma development.

Stéphanie Lhomond, Tony Avril, Nicolas Dejeans

Pageof 4

Frequent Collaborators

6 joint publications

Olga Papadodima

5 joint publications

Eleftherios Pilalis

4 joint publications

Afshin Samali

3 joint publications

Georgia Kontogianni